The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.00
Change: -0.075 (-0.40%)
Spread: 0.65 (3.542%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

3 Jan 2023 15:30

RNS Number : 5561L
BATM Advanced Communications Ld
03 January 2023
 

LEI: 213800FLQUB9J289RU66

3 January 2023

 

BATM Advanced Communications Limited

("BATM" or "the Company")

 

Grant of Options

 

Further to the Company's announcements of 24 November and 21 December 2022, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that the Company granted, on 1 January 2023 (the "Grant Date"), options over ordinary shares of 0.01 NIS each in the capital of the Company ("Ordinary Shares") to certain Directors as follows:

 

Name

Role

Number of options granted

Options exercise price

Period and conditions of vesting

Gideon Chitayat*

Chairman

1,229,369

25.49 pence

The options fully vest on the first anniversary of the Grant Date.

Moti Nagar

CEO

16,433,937

25.49 pence

 

One-third of the options will vest on each of the first, second and third anniversaries of the Grant Date.

* Dr. Chitayat's options were granted to GMBS General Management & Business Strategy Consultants Ltd., a service company through which Dr. Chitayat provides his services to the Company

 

The options were granted under the BATM Advanced Communications Ltd. Global Share Incentive Plan (2021) ("SIP (2021)"). The exercise price represents the average closing price of the Company's Ordinary Shares on the London Stock Exchange over the 30 trading days preceding the Grant Date. The options granted to Mr. Nagar have a total grant value of 2% of the value of the Company on the Grant Date, as approved by shareholders at the Company's annual general meeting of 21 December 2022. Each grantee's options are exercisable subject to that grantee remaining a service provider of the Company and for 90 days thereafter.

 

Following the above option grants, Mr. Nagar and Dr. Chitayat hold options over Ordinary Shares and Restricted Share Units ("RSUs") as detailed below:

 

Instrument

Scheme

Number

Date of grant

Exercise price (if applicable)

Date of first vesting

Conditions of vesting/exercise*

Expiry date (if applicable)

Gideon Chitayat, Chairman

Options over Ordinary Shares

SIP (2021)

1,229,369

01/01/23

25.49 pence

01/01/24

The options fully vest on the first anniversary of the grant date.

01/01/33

Moti Nagar, CEO

Options over Ordinary Shares

ESOP (2004)

906,200

05/05/15

12.69 pence

31/12/16

The options are fully vested and are exercisable.

04/05/25

SIP (2021)

16,433,937

01/01/23

25.49 pence

01/01/24

The options vest equally on the first, second and third anniversaries of the date of grant.

01/01/33

Restricted Share Units

SIP (2021)

537,109

12/04/22

N/A

12/04/25

The RSUs vest on the third anniversary of the grant date subject to total shareholder return performance over the three-year period (for details, see page 56 of BATM's Annual Report 2021). If, and to the extent that, these RSUs vest, the resulting ordinary shares will be subject to a two-year holding period, however, sufficient awards may be sold during the holding period to satisfy any tax liabilities owed. 

N/A

 

* All options and RSUs are subject to the provisions of the scheme under which they were granted and are exercisable subject to the grantee remaining a service provider of the Company and for 90 days thereafter.

 

Enquiries:

 

BATM Advanced Communications

Moti Nagar, Chief Executive Officer

+972 9866 2525

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Gideon Chitayat

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BATM ADVANCED COMMUNICATIONS LTD

b)

 

LEI

 

 

213800FLQUB9J289RU66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.01 NIS each

Identification code

IL0010849045

b)

 

Nature of the transaction

 

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

25.49 pence

1,229,369

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

1 January 2023

 

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Moti Nagar

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BATM ADVANCED COMMUNICATIONS LTD

b)

 

LEI

 

 

213800FLQUB9J289RU66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 0.01 NIS each

Identification code

IL0010849045

b)

 

Nature of the transaction

 

 

Grant of options

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

25.49 pence

16,433,937

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

1 January 2023

 

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLELEIVIIV
Date   Source Headline
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.